These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17202549)

  • 1. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial.
    Greeven A; van Balkom AJ; Visser S; Merkelbach JW; van Rood YR; van Dyck R; Van der Does AJ; Zitman FG; Spinhoven P
    Am J Psychiatry; 2007 Jan; 164(1):91-9. PubMed ID: 17202549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up.
    Greeven A; van Balkom AJ; van der Leeden R; Merkelbach JW; van den Heuvel OA; Spinhoven P
    J Behav Ther Exp Psychiatry; 2009 Sep; 40(3):487-96. PubMed ID: 19616195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis.
    Fallon BA; Ahern DK; Pavlicova M; Slavov I; Skritskya N; Barsky AJ
    Am J Psychiatry; 2017 Aug; 174(8):756-764. PubMed ID: 28659038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine.
    Spinhoven P; Van der Does AJ; Van Dijk E; Van Rood YR
    J Psychosom Res; 2010 Sep; 69(3):227-35. PubMed ID: 20708444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.
    Weiss M; Hechtman L;
    J Clin Psychiatry; 2006 Apr; 67(4):611-9. PubMed ID: 16669726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
    J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality change during depression treatment: a placebo-controlled trial.
    Tang TZ; DeRubeis RJ; Hollon SD; Amsterdam J; Shelton R; Schalet B
    Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design.
    Fineberg NA; Pellegrini L; Clarke A; Perera U; Drummond LM; Albert U; Laws KR
    Compr Psychiatry; 2022 Oct; 118():152334. PubMed ID: 36007340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.
    Elliott AJ; Uldall KK; Bergam K; Russo J; Claypoole K; Roy-Byrne PP
    Am J Psychiatry; 1998 Mar; 155(3):367-72. PubMed ID: 9501747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.
    Misri S; Reebye P; Corral M; Milis L
    J Clin Psychiatry; 2004 Sep; 65(9):1236-41. PubMed ID: 15367052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
    Liebowitz MR; Stein MB; Tancer M; Carpenter D; Oakes R; Pitts CD
    J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.
    Wagner KD; Berard R; Stein MB; Wetherhold E; Carpenter DJ; Perera P; Gee M; Davy K; Machin A
    Arch Gen Psychiatry; 2004 Nov; 61(11):1153-62. PubMed ID: 15520363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
    Kim SW; Grant JE; Adson DE; Shin YC; Zaninelli R
    J Clin Psychiatry; 2002 Jun; 63(6):501-7. PubMed ID: 12088161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine, Cognitive Therapy or Their Combination in the Treatment of Social Anxiety Disorder with and without Avoidant Personality Disorder: A Randomized Clinical Trial.
    Nordahl HM; Vogel PA; Morken G; Stiles TC; Sandvik P; Wells A
    Psychother Psychosom; 2016; 85(6):346-356. PubMed ID: 27744447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial.
    Schneier FR; Neria Y; Pavlicova M; Hembree E; Suh EJ; Amsel L; Marshall RD
    Am J Psychiatry; 2012 Jan; 169(1):80-8. PubMed ID: 21908494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.